Sean Duffy, a director and officer at Omada Health, Inc., has filed a notice to sell 12,944 shares of the company's common stock. This transaction, valued at approximately $240,499.52, is part of a planned sale under a 10b5-1 trading plan.

The filing, dated November 4, 2026, indicates that Duffy acquired these shares through the exercise of stock options on the same day. This move follows a series of sales made under the same trading plan, which allows company insiders to sell shares at predetermined times, reducing the risk of insider trading allegations.

Background

Omada Health, Inc. operates in the health services sector, focusing on providing digital health solutions. The company is incorporated in Delaware and has its business address in South San Francisco, California. Omada Health is publicly traded on the NASDAQ under the SEC file number 001-42679.

What the Filing Says

The filing states, "Sean Duffy plans to sell 12,944 shares of common stock, valued at $240,499.52, as part of a 10b5-1 plan." This indicates a structured approach to selling shares while complying with regulations.

Impact

This transaction may affect Omada Health's stock performance and investor sentiment, particularly as insiders liquidate portions of their holdings. The health services industry may also face increased scrutiny regarding insider trading practices, especially as more executives engage in similar transactions.

What's Next

The filing does not say what happens next.